middle.news
Racura Oncology Teams with Emory to Tackle Osimertinib Resistance in Lung Cancer
9:14am on Wednesday 14th of January, 2026 AEDT
•
Healthcare
Read Story
Racura Oncology Teams with Emory to Tackle Osimertinib Resistance in Lung Cancer
9:14am on Wednesday 14th of January, 2026 AEDT
Key Points
Collaboration with Emory University led by Prof. Shi-Yong Sun
Focus on (E,E)-bisantrene (RC220) to combat osimertinib resistance in EGFRm NSCLC
Access to Emory’s specialized osimertinib-resistant cell and mouse models
Supports ongoing HARNESS-1 Phase 1a/b clinical trial
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Racura Oncology (ASX:RAC)
OPEN ARTICLE